Clinical trials in multiple sclerosis: potential future trial designs

Clinical trials of new treatments in multiple sclerosis (MS) currently require large sample sizes and long durations in order to yield reliable results. The differential responses of an already heterogeneous population of MS patients to individual disease-modifying therapies (DMTs) will further comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Manouchehri, Navid, Zhang, Yinan, Salter, Amber, Hussain, Rehana Z., Hartung, Hans-Peter, Hemmer, Bernhard, Linker, Ralf, Segal, Benjamin M., Cutter, Gary, Stüve, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535717/
https://www.ncbi.nlm.nih.gov/pubmed/31205492
http://dx.doi.org/10.1177/1756286419847095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535717/
https://www.ncbi.nlm.nih.gov/pubmed/31205492
http://dx.doi.org/10.1177/1756286419847095

Ejemplares similares